MedPath

Rehabilitation trial using curara(R) for patients with spinocerebellar degeneratio

Phase 2
Conditions
spinocerebellar degeneration (SCD)
Registration Number
JPRN-jRCTs032180164
Lead Sponsor
Yoshida Kunihiro
Brief Summary

We conducted a single-arm study using curara for cerebellar ataxia patients. Of 20 patients enrolled, 19 completed the program without any adverse effects and one withdrew on day 3. The mean improvement rate of 10 m walking time in this study was almost equivalent to that in the previous study, which was a multidisciplinary, intensive, inpatient rehabilitation program of 28 days. We think gait training with curara is potentially useful for cerebellar ataxia patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

1) Patients with spinocerebellar degeneration (SCD)
2) Age: 20 years <= at entry
3) Able to walk 10 m (even with walking aids such as cane or walker)
4) Able to keep admission in Kakeyu-Misayama Rehabilitation Center, Kakeyu Hospital during the study
5) Berg Balance Scale: 20 <=
6) Written informed consent for the study

Exclusion Criteria

1) Possible causes for gait disturbance other than SCD
2) Not fulfil the body-size criteria for curara(R) model 4
3) Researchers judge the participants inappropriate for the study (for example, severe dementia or psychiatric symptoms, severe spasticity or joint contractures of the legs)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath